Will transfer commercial manufacturing for a leading injectable pharmaceutical product from the current manufacturer to Lifecore’s facilities. Read More >>
Funding supports advancement of Excalipoint’s proprietary platforms and a pipeline of six differentiated programs with first- or best-in-class potential.
New perfusion‑based adherent cell‑culture bioreactor is designed to scale cell therapy manufacturing with integrated process monitoring and automated harvesting.
Brainin brings a combination of cardiovascular medicine, clinical research, and venture investing experience across EU and U.S. biotechnology companies.
